VERVE-101

FDA Outlines Path Forward for Verve’s Lead Candidate, VERVE-101
BioSpace
Mon, 12/5/22 - 10:55 pm
Verve Therapeutics
VERVE-101
FDA
heterozygous familial hypercholesterolemia
Do Verve's gene edits pass down to patients' children? The FDA wants to know
Fierce Biotech
Mon, 12/5/22 - 10:42 am
Verve Therapeutics
gene editing
gene therapy
FDA
VERVE-101
FDA Pauses Verve’s Trial Plan for Gene-Editing Therapy for High Cholesterol
MedCity News
Mon, 11/7/22 - 05:17 pm
Verve Therapeutics
gene editing
FDA
heterozygous familial hypercholesterolemia
VERVE-101
HeFH
JPM: Verve Therapeutics unveils its lead program—a one-and-done treatment for genetic high cholesterol
Fierce Biotech
Tue, 01/12/21 - 11:11 am
JPMHC 2021
Verve Therapeutics
VERVE-101
familial hypercholesterolemia